Full Papers
doi.org/10.1002/ejoc.202100194
*
+
(
7
11), 136 (9), 135 (68), 134 (18), 108 (19), 107 (10), 106 (8), 104 (6),
9 (10), 78 (27), 77 (17).
(27, [M] ), 242 (100), 241 (16), 229 (4), 213 (7), 212 (4), 211 (6), 187
(7), 186 (76), 185 (32), 184 (80), 183 (25), 158 (7), 156 (7), 105 (5), 78
(
6), 76 (7), 51 (6).
[
32]
4
-(4-Methylphenyl)morpholine (1j). Reaction time: 4 h. Yellow
1
[35]
solid (300 mg, 42%). mp 41.9°C. H NMR (400 MHz, CDCl ): δ 7.10
4-(Thiophen-3-yl)morpholine (1q). Reaction time: 21 h. Brown
3
1
(
3
1
(
d, J=8.2 Hz, 2H), 6.85 (d, J=8.3 Hz, 2H), 3.88–3.86 (m, 4H), 3.13–
solid (203 mg, 30%). mp 87.1°C. H NMR (400 MHz, CDCl ): δ 7.27-
3
13
1
.11 (m, 4H), 2.29 (s, 3H). C{ H} NMR (100 MHz, CDCl ): δ 149.2,
7.24 (m, 1H), 6.86 (dt, J=5.3, 1.6 Hz, 1H), 6.21–6.20 (m, 1H), 3.86–
3
1
3
1
29.7, 129.6, 116.1, 67.0, 50.0, 20.5. MS, m/z (relative intensity): 178
15), 177 (100, [M] ), 176 (17), 162 (3), 146 (7), 133 (3), 132 (8), 130
3), 120 (8), 119 (79), 118 (41), 117 (5), 92 (7), 91 (82), 90 (3), 89 (5),
3.83 (m, 4H), 3.09 (td, J=4.7, 1.7 Hz, 4H). C{ H} NMR (100 MHz,
*
+
CDCl ): δ 152.4, 125.6, 119.6, 100.5, 66.7, 50.8. MS, m/z (relative
intensity): 171 (5), 170 (13), 169 (100, [M] ), 168 (9), 167 (4), 156 (3),
155 (6), 154 (63), 140 (8), 138 (6), 126 (4), 113 (4), 112 (10), 111 (68),
3
*
+
(
7
7 (5), 65 (11), 63 (3), 51 (2).
1
10 (74), 97 (5), 85 (3), 84 (18), 83 (6), 58 (6).
[
24]
4
(
-(3-Methylphenyl)morpholine (1j’).
Reaction time: 4 h. Oil
1
[24]
380 mg, 54%). H NMR (400 MHz, CDCl ): δ 7.24 (t, J=7.7 Hz, 1H),
.81–6.78 (m, 3H), 3.93–3.91 (m, 4H), 3.21–3.19 (m, 4H), 2.40 (s, 3H).
C{ H} NMR (100 MHz, CDCl ): δ 151.4, 138.9, 129.1, 121.1, 116.7,
13.0, 67.0, 49.6, 21.9. MS, m/z (relative intensity): 178 (14), 177
1-(4-(Trifluoromethyl)phenyl)pyrrolidine (2b). Reaction time: 2.5 h.
3
1
6
White solid (455 mg, 53%). mp 94.0°C. H NMR (400 MHz, CDCl ): δ
3
13
1
7.47 (d, J=8.4 Hz, 2H), 6.57 (d, J=8.4 Hz, 2H), 3.33 (d, J=6.1 Hz, 4H),
3
19
1
1
2.05 (dt, J=4.4, 2.8 Hz, 4H). F{ H} NMR (376 MHz, CDCl ): δ À 60.51.
3
*
+
13
1
3
(
1
100, [M] ), 176 (20), 162 (6), 146 (10), 132 (14), 120 (8), 119 (75),
C{ H} NMR (100 MHz, CDCl ): δ 149.8, 126.4 (q, J =3.8 Hz), 125.5 (q,
3 C-F
2
1
18 (62), 92 (8), 91 (57), 65 (11).
JC-F =269.9 Hz), 116.6 (q, JC-F =32.5 Hz), 110.9, 47.5, 25.5. MS, m/z
*
+
(
1
relative intensity): 216 (13), 215 (64, [M] ), 214 (100), 196 (7), 172 (14),
59 (17), 145 (12).
[
32]
4
-(4-(Tert-butyl)phenyl)morpholine (1k).
Reaction time: 4 h.
1
White solid (282 mg, 32%). mp 96.0°C. H NMR (400 MHz, CDCl ): δ
3
[
36]
7
3
1
.32 (d, J=8.1 Hz, 2H), 6.88 (d, J=8.2 Hz, 2H), 3.88–3.86 (m, 4H),
1-Methyl-4-(4-(trifluoromethyl)phenyl)piperazine (2c). Reaction
13
1
1
.16–3.14 (m, 4H), 1.31 (s, 9H). C{ H} NMR (100 MHz, CDCl ): δ
time: 3 h. Yellow solid (454 mg, 46%). mp 88.6°C. H NMR
3
48.9, 142.9, 126.0, 115.5, 67.0, 49.6, 34.0, 31.5. MS, m/z (relative
(400 MHz, CDCl ): δ 7.48 (d, J=8.5 Hz, 2H), 6.93 (d, J=8.5 Hz, 2H),
3
.
+
19
1
intensity): 220 (5, [M+H] ), 219 (32), 205 (15), 204 (100), 202 (2),
89 (3), 160 (5), 159 (4), 158 (2), 146 (9), 145 (3), 144 (2), 132 (3), 131
4), 130 (4), 118 (5), 117 (4), 115 (2), 91 (3), 77 (3).
3.32–3.29 (m, 4H), 2.59-2.56 (m, 4H), 2.36 (s, 3H). F{ H} NMR
13 1
1
(
(376 MHz, CDCl ): δ À 61.35. C{ H} NMR (100 MHz, CDCl ): δ 153.3,
3 1 2
3
3
126.4 (q, J =3.8 Hz), 124.8 (q, JC-F =270.7 Hz), 120.4 (q, JC-F =
C-F
3
2
2.8 Hz), 114.5, 54.8, 47.9, 46.1. MS, m/z (relative intensity): 245 (14),
44 (100, [M] ), 243 (16), 229 (16), 225 (14), 202 (14), 201 (10), 200
[
24]
4
-(Naphthalen-1-yl)morpholine (1m). Reaction time: 3 h. Brown
*
+
1
solid (255 mg, 30%). mp 83.3°C. H NMR (400 MHz, CDCl ): δ 8.24
3
(17), 174 (7), 173 (27), 172 (34), 159 (6), 145 (19), 70 (10).
(
d, J=7.9 Hz, 1H), 7.84 (d, J=7.5 Hz, 1H), 7.59 (d, J=8.1 Hz, 1H),
[36]
7
4
1
(
(
(
.54–7.45 (m, 2H), 7.45–7.37 (m, 1H), 7.12 (d, J=6.8 Hz, 1H), 4.01 (s,
1-Phenyl-4-(4-(trifluoromethyl)phenyl)piperazine (2d). Reaction
13
1
1
H), 3.14 (s, 4H). C{ H} NMR (100 MHz, CDCl ): δ 134.8, 128.7, 128.5,
26.5, 126.0, 125.9, 125.6, 124.1, 123.4, 114.8, 67.4, 53.6. MS, m/z
relative intensity): 214 (16), 213 (100, [M] ), 212 (22), 211 (3), 198
4), 183 (3), 182 (6), 168 (4), 167 (5), 156 (6), 155 (47), 154 (78), 153
2), 141 (4), 128 (8), 127 (22), 126 (6), 115 (4), 77 (3), 75 (3).
time: 4 h. Brown solid (215 mg, 18%). mp 63.7°C. H NMR (400 MHz,
3
CDCl ): δ 7.53 (d, J=8.4 Hz, 2H), 7.33 (t, J=7.7 Hz, 2H), 7.03–6.95
3
*
+
19
1
(m, 5H), 3.46 (t, J=4.7 Hz, 4H), 3.36 (t, J=4.7 Hz, 4H). F{ H} NMR
13 1
(376 MHz, CDCl ): δ À 61.29. C{ H} NMR (100 MHz, CDCl ): δ 153.2,
3
3
3
1
150.9, 129.3, 126.5 (q, J =3.8 Hz), 124.8 (q, J =270.7 Hz), 120.9
C-F
C-F
2
(q, J =11.9 Hz), 120.6, 116.6, 114.8, 49.4, 48.1. MS, m/z (relative
C-F
*
+
[
24]
4
-(Naphthalen-2-yl)morpholine (1 m’). Reaction time: 3 h. Pink
intensity): 307 (21), 306 (100, [M] ), 305 (8), 291 (16), 287 (7), 264
14), 201 (5), 200 (26), 173 (27), 172 (28), 145 (13), 132 (22), 106 (6),
05 (20), 104 (27), 91 (6), 77 (13).
1
solid (293 mg, 34%). mp 84.0°C. H NMR (400 MHz, CDCl ): δ 7.76–
3
(
1
7
(
.69 (m, 3H), 7.42 (t, J=7.5 Hz, 1H), 7.31 (t, J=7.4 Hz, 1H), 7.29–7.24
13 1
m, 1H), 7.13 (s, 1H), 3.94–3.91 (m, 4H), 3.28–3.26 (m, 4H). C{ H}
NMR (100 MHz, CDCl ): δ 149.1, 134.6, 128.9, 128.7, 127.5, 126.8,
1-Benzyl-4-(4-(trifluoromethyl)phenyl)piperazine (2e). Reaction
3
1
1
26.4, 123.6, 119.0, 110.2, 67.0, 49.9. MS, m/z (relative intensity): 214
time: 3.5 h. Yellow solid (507 mg, 40%). mp 85.0°C. H NMR
*
+
(16), 213 (100, [M] ), 212 (10), 198 (17), 182 (7), 156 (12), 155 (81),
(400 MHz, CDCl ): δ 7.47 (d, J=8.5 Hz, 2H), 7.42–7.23 (m, 5H), 6.91
3
154 (25), 128 (20), 127 (20), 126 (6).
(d, J=8.5 Hz, 2H), 3.58 (d, J=1.4 Hz, 2H), 3.30– 3.27 (m, 4H), 2.63–
1
9
1
13
1
2
(
3
6
.60 (m, 4H). F{ H} NMR (376 MHz, CDCl ): δ À 61.30. C{ H} NMR
[
33]
3
4
3
-(6-Methoxynaphthalen-2-yl)morpholine (1n).
Reaction time:
3
100 MHz, CDCl ): δ 153.4, 137.7, 129.3, 128.4, 127.3, 126.4 (q, J
.8 Hz), 124.8 (q, JC-F =270.5 Hz), 120.4 (q, JC-F =32.7 Hz), 114.5,
3.0, 52.8, 48.0. MS, m/z (relative intensity): 321 (22), 320 (100,
=
1
3
C-F
h. Pink solid (260 mg, 27%). mp 150.0°C. H NMR (400 MHz,
1
2
CDCl ): δ 7.64 (dd, J=17.1, 8.9 Hz, 2H), 7.23 (s, 1H), 7.11–7.07 (m,
3
1
3
1
3
H), 3.96–3.89 (m, 4H), 3.23 (t, J=4.7 Hz, 4H), 1.57 (s, 3H). C{ H}
*
+
[
M] ), 319 (10), 301 (15), 292 (6), 229 (11), 202 (15), 200 (8), 189 (6),
NMR (100 MHz, CDCl ): δ 156.2, 147.7, 129.8, 129.6, 128.4, 127.7,
3
1
74 (11), 173 (9), 172 (18), 146 (16), 145 (16), 132 (6), 119 (32), 118
1
19.7, 119.0, 110.8, 105.8, 67.0, 55.3, 50.3. MS, m/z (relative
+
*
+
(48), 91 (34), 65 (7). HRMS (ESI ) m/z calcd for C18H F N [M+H],
20 3 2
intensity): 244 (17), 243 (100, [M] ), 242 (5), 229 (5), 228 (32), 186
321.1573; found, 321.1571.
(11), 185 (69), 171 (8), 170 (34), 142 (17), 115 (8).
[
37]
1
2
8
-(4-(Trifluoromethyl)phenyl)piperidine (2f).
Reaction time:
[
24]
4
5
7
-(Pyridin-3-yl)morpholine (1o). Reaction time: 5 h. Oil (360 mg,
1
.5 h. Oil (566 mg, 62%). H NMR (400 MHz, CDCl ): δ 7.45 (d, J=
.5 Hz, 2H), 6.91 (d, J=8.5 Hz, 2H), 3.27 (t, J=5.2 Hz, 4H), 1.66 (dt,
1
3
5%). H NMR (400 MHz, CDCl ): δ 8.29 (s, 1H), 8.12–8.10 (m, 1H),
.17–7.15 (m, 2H), 3.87-3.85 (m, 4H), 3.18-3.16 (m, 4H). C{ H} NMR
3
13
1
19
1
13
1
J=23.6, 5.2 Hz, 6H). F{ H} NMR (376 MHz, CDCl ): δ À 61.14. C{ H}
3
(
100 MHz, CDCl ): δ 146.9, 141.1, 138.3, 123.5, 122.1, 66.7, 48.6. MS,
3
1
3
*
+
NMR (100 MHz, CDCl ): δ 153.8, 126.3 (q, JC-F =3.8 Hz), 124.9 (q, JC-
3
2
m/z (relative intensity): 165 (9), 164 (100, [M] ), 163 (25), 162 (4),
49 (2), 135 (2), 134 (4), 133 (10), 119 (3), 107 (11), 106 (81), 105
66), 92 (2), 80 (2), 79 (7), 78 (35), 65 (2), 52 (5), 51 (13), 50 (3).
=270.5 Hz), 119.5 (q, J =32.6 Hz), 114.6, 49.3, 25.4, 24.3. MS, m/z
C-F
*
+
F
1
(
(relative intensity): 230 (9), 229 (57, [M] ), 228 (100), 210 (7), 200
(13), 188 (8), 173 (12), 172 (22), 145 (12).
[
34]
4
-(5-Bromopyridin-3-yl)morpholine (1p).
Reaction time: 4.5 h.
2-(4-(Trifluoromethyl)phenyl)-1,2,3,4-tetrahydroiso
quinoline
1
[38]
Pink solid (325 mg, 33%). mp 82.2°C. H NMR (400 MHz, CDCl ): δ
(2g). Reaction time: 2.5 h. White solid (448 mg, 43%). mp 82.7°C.
3
1
8
4
1
.17 (s, 1H), 8.12 (s, 1H), 7.26 (s, 1H), 3.84–3.82 (m, 4H), 3.18–3.16 (m,
H NMR (400 MHz, CDCl ): δ 7.51 (d, J=8.5 Hz, 2H), 7.24-7.18 (m,
3
13
1
H). C{ H} NMR (100 MHz, CDCl ): δ 147.8, 141.3, 136.1, 124.2,
4H), 6.94 (d, J=8.5 Hz, 2H), 4.49 (s, 2H), 3.64 (t, J=5.6 Hz, 2H), 3.00
3
1
9
1
13
1
20.9, 66.5, 48.1. MS, m/z (relative intensity): 245 (11), 244 (93), 243
(t, J=5.9 Hz, 2H). F{ H} NMR (376 MHz, CDCl ): δ À 61.02. C{ H}
3
Eur. J. Org. Chem. 2021, 2462–2469
2467
© 2021 Wiley-VCH GmbH